AI-HEART Lab Clinical Tools
2026 Dyslipidemia Guideline Calculator
Interactive decision-support tool implementing the complete 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia. PREVENT-ASCVD risk assessment, treatment algorithms, and guideline-directed recommendations.
PREVENT Risk Calculator
Calculate 10-year and 30-year ASCVD risk using the PREVENT equations.
Primary Prevention
CPR framework: Calculate, Personalize, Reclassify with risk-enhancing factors and CAC.
Secondary Prevention
ASCVD treatment cascade with high/very-high risk stratification.
Severe Hyperchol. & FH
Dutch Lipid Clinic Network Score, LDL-C >=190 pathway, and Lp(a) assessment.
Hypertriglyceridemia
TG classification, pancreatitis risk, IPE eligibility, and management pathways.
Diabetes
Type 1 & Type 2 lipid management with CKM syndrome integration.
Special Populations
CKD, HIV, pregnancy, pediatric, elderly, and organ transplant.
Lp(a) & ApoB
Lipoprotein(a) interpretation and apoB discordance analysis.
Monitoring & Follow-Up
Lab schedules, statin intolerance management, and goal attainment.
About This Tool
This calculator implements the PREVENT (Predicting Risk of cardiovascular disease EVENTs) equations, which replace the Pooled Cohort Equations used since 2013. The PREVENT model incorporates eGFR and BMI as additional predictors and was developed using data from over 6 million adults.
The tool operationalizes the complete 2026 ACC/AHA/Multisociety Guideline on the Management of Dyslipidemia across 9 interactive modules: risk assessment, primary prevention (CPR framework), secondary prevention with treatment cascade, severe hypercholesterolemia & FH (DLCN scoring), hypertriglyceridemia (IPE eligibility), diabetes-specific management, special populations (CKD, HIV, pregnancy, pediatric, elderly, transplant), Lp(a)/ApoB discordance analysis, and monitoring & follow-up.
All computation occurs entirely in your browser. No patient data is transmitted to any server, stored, or logged. This tool is HIPAA-irrelevant by design.
This tool is intended for use by healthcare professionals and does not replace clinical judgment. Always refer to the full 2026 ACC/AHA Guideline on the Management of Dyslipidemia for complete recommendations.
Reference
Blumenthal R, Morris P, Gaudino M, et al. 2026 ACC/AHA/AACVPR/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Dyslipidemia: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. JACC. 2026;0(0). doi:10.1016/j.jacc.2025.11.016
Developed by AI-HEART Lab
Built by Dr. Rahul Chaudhary, a physician-scientist with 150+ publications and 18 international guideline citations, trained at Johns Hopkins, Mayo Clinic, and UPMC.